Home › Employers › Emergent Travel Health Inc.
Emergent Travel Health Inc.: H-1B salaries and sponsorship
Emergent Travel Health Inc. filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $136,490.
Does Emergent Travel Health Inc. sponsor H-1B visas?
Emergent Travel Health Inc. filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on May 10, 2022. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Manager, Regulatory Affairs | 1 | $136,490 |
| Process Development Sr. Scientist, Downstream | 1 | $145,000 |
| Product Development Scientist | 1 | $107,882 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2023 | 3 | $136,490 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Manager, Regulatory Affairs | $136,490 Level II | Redwood City, CA | May 10, 2022 | Jun 1, 2022 | Certified, then withdrawn |
| Process Development Sr. Scientist, Downstream | $145,000 Level III | San Diego, CA | Feb 22, 2022 | Mar 7, 2022 | Certified, then withdrawn |
| Product Development Scientist | $107,882 Level IV | San Diego, CA | Apr 23, 2021 | Aug 29, 2021 | Certified, then withdrawn |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).